Strides Pharma Science share news and announcements
NSE: STARBSE: 532531Pharmaceuticals & BiotechnologySmall Cap
Formerly Strides Shasun
Last close ₹1,014.80up ₹16.40 (1.64%)BSE ₹1,012.15
Share price at the NSE close on 23 Oct 2026. Previous close ₹998.40.
52-week range of traded prices to 23 Oct 2026
₹768.65Low, 29 Jan 2026₹1,260.90High, 21 Sep 2026
- Next results date: the board meets on 29 Oct 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹9,354 Cr580th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- 15.2
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- 3.0
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.49%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 21.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 15.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.53
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 3,12,38541.2% delivered
Strides Pharma Science share news and announcements
1,456 announcements, routine notices left out, newest first. Page 19 of 30.
Jan 2015
Dec 2014
Nov 2014
Oct 2014
29 Oct · Board meeting
To consider inter-alia, the unaudited financial results of the Company for the quarter ended September 30, 2014.7 Oct · Dividend
Special Dividend will be paid on or after October 22, 2014.7 Oct · Corporate action
Company has fixed Record Date as October 17, 2014 for the purpose of payment of special dividend.7 Oct · Dividend
Board of Directors at its meeting held on October 07, 2014 have approved a Special Dividend of Rs.105/- (Rupees One Hundred Five Only) per equity share of Rs.10/- each to the shareholders of the Company.
Sep 2014
29 Sep · Board meeting
To consider declaration of special dividend.12 Sep · Meeting
Shareholders of the Company at the Annual General Meeting of the Company held on September 09, 2014 have approved a final dividend of Rs.5/- per equity share of face value Rs .10/- each.12 Sep · Dividend
Dividend payout date shall be on or after September 17, 2014.12 Sep · Disclosure of Voting Pattern - Clause 35A
Aug 2014
14 Aug · Meeting
Company has fixed Book Closure from September 3, 2014 to September 9, 2014 (both days inclusive) for the purpose of payment of dividend on equity shares for the 15 month period ended March 31, 2014, if declared and Annual General Meeting of the Company scheduled to be held on September 9, 2014.
Jul 2014
17 Jul · Board meeting
To consider inter-alia, the unaudited financial results of the Company for the quarter ended June 30, 2014. Further, as per the provisions of the Company's Code for Prevention of Insider Trading, trading window for Designated Employees of the Company will remain closed from July 15, 2014 to July 26, 2014 (both days inclusive).
Jun 2014
May 2014
26 May · Management
As per the provisions of Section 283(1)(g) of the Companies Act, 1956, Mr K.R Ravishankar, Non-Executive Director of the Company, ceases to be a Director of the Company w.e.f February 07, 2014.
Apr 2014
3 Apr · Legal
Spurt in Volume : Substantial increase in trading volumes have been observed in Strides Arcolab Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Strides Arcolab Limited has vide its letter inter-alia stated, "We wish to clarify that there are no material events/price sensitive information/announcement (including impending announcement) which the Company has not disclosed to the Exchanges."
Feb 2014
Jan 2014
30 Jan · Board meeting
To consider inter-alia, the unaudited financial results of the Company for the quarter ended December 31, 2013.Further, as per the provisions of the Company s Code for Prevention of Insider Trading, trading window for Designated Employees of the Company will remain closed from January 28, 2014 to February 8, 2014 (both days inclusive).28 Jan · Rating
India Ratings & Research (India Ratings), a Fitch Group Company, has upgraded Strides Arcolab Limited's (Strides) Long- Term Issuer rating to 'A+' from 'BBB+'.